Wellcome Trust Reports - Drug-resistant infections: transforming the global response
The Wellcome Trust has produce a series of policy reports and consultations aimed at combating AMR:
Reports and consultations
Reframing Resistance. How to communicate about antimicrobial resistance effectively – Wellcome’s report and practical toolkit aims to guide experts, communicators and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.
Response to the Open Consultation on Proposals Received for the 2020 Comprehensive Review of the Global Indicator Framework [PDF 103KB] – Specifically in relation to inclusion of an antimicrobial resistance-specific indicator within the Sustainable Development Goals.
Call to Action on Antimicrobial Resistance [PDF 1.9MB] – The key outcomes from the Call to Action on Antimicrobial Resistance event, organised by Wellcome in partnership with the UK, Ghanaian and Thai governments and the UN Foundation.
Call to Action on Antimicrobial Resistance 2018 Report [PDF 1.4MB] – Key outcomes from the second Call to Action on Antimicrobial Resistance held in Ghana, co-hosted by the Governments of Ghana, Thailand and the UK, along with the World Bank, UN Foundation and Wellcome.
The Ghana Declaration, Call to Action on Antimicrobial Resistance [PDF 927KB] – The Ghana Declaration signed by the co-hosts of the Call to Action on Antimicrobial Resistance, together with civil society leaders, heads of private sector companies and the World Health Organization, the Food and Agriculture Organization and the World Organisation for Animal Health.
Addressing antimicrobial resistance in the environment [PDF 1.9MB] – This scientific white paper looks at the evidence about how antimicrobial resistance in the environment is impacting human health, and at how the risks can be addressed.
Vaccines for antimicrobial resistance(opens in a new tab) – This report, commissioned by Wellcome and produced by Boston Consulting Group, looks at the opportunities and challenges around developing vaccines to combat antimicrobial resistance.
Antimicrobial resistance surveillance: sharing industry data [PDF 1.1MB] – Recommendations from a pilot project to openly publish human antimicrobial resistance surveillance data generated and collected by the pharmaceutical industry. The project was led by the Open Data Institute and funded by Wellcome.
See all of our reports on drug-resistant infections.